Top

Published in:

Open Access 01-01-2021 | Laparoscopy | Case report

Peritoneal dissemination of breast cancer diagnosed by laparoscopy

Authors: Tsuyoshi Nakagawa, Goshi Oda, Akifumi Kikuchi, Toshifumi Saito, Tomoyuki Fujioka, Kazunori Kubota, Mio Mori, Iichiro Onishi, Hiroyuki Uetake

Published in: International Cancer Conference Journal | Issue 1/2021

Abstract

The accuracy of modern imaging techniques for the diagnosis of peritoneal carcinomatosis is poor. A breast cancer patient with a high serum CA15-3 level did not receive a definitive diagnosis of peritoneal dissemination by imaging examination and then underwent laparoscopy. Pathological examination showed peritoneal dissemination of breast cancer, but the biological markers were different from the primary lesion: ER(−), PgR(−), and Her2:3 +. T-DM1 therapy was very effective, and her systemic symptoms disappeared. Since biomarkers of metastatic lesions may sometimes change, laparoscopic biopsy is very important and useful.

Bertozzi S, Londero AP, Cedolini C et al (2015) Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. Springerplus 4:688CrossRef

Fujii K, Watanabe R, Ando T et al (2017) Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions. Biomed Rep 7:535–542PubMedPubMedCentral

Fukagawa T (2019) Role of staging laparoscopy for gastric cancer patients. Ann Gastroenterol Surg 3:496–505CrossRef

Sperlongano P, Pisaniello D, Piatto A et al (2006) The role of laparoscopy in pancreatic surgery. Front Biosci 11:2203–2205CrossRef

Stefanidis D, Grove KD, Schwesinger WH et al (2006) The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol 17:189–199CrossRef

Irino T, Sano T, Hiki N et al (2018) Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc 32:268–275CrossRef

Yamagata Y, Amikura K, Kawashima Y et al (2013) Staging laparoscopy in advanced gastric cancer: usefulness and issues requiring improvement. Hepatogastroenterology 60:751–755PubMed

Ishigami S, Uenosono Y, Arigami T et al (2014) Clinical utility of perioperative staging laparoscopy for advanced gastric cancer. World J Surg Oncol 12:350CrossRef

Miki Y, Tokunaga M, Tanizawa Y et al (2015) Staging laparoscopy for patients with cM0, type 4, and large type 3 gastric cancer. World J Surg 39:2742–2747CrossRef

10.

Hosogi H, Shinohara H, Tsunoda S et al (2017) Staging laparoscopy for advanced gastric cancer: significance of preoperative clinicopathological factors. Langenbecks Arch Surg 402:33–39CrossRef

11.

Nakagawa S, Nashimoto A, Yabusaki H (2007) Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer 10:29–34CrossRef

12.

Tsuchida K, Yoshikawa T, Tsuburaya A et al (2011) Indications for staging laparoscopy in clinical T4M0 gastric cancer. World J Surg 35:2703–2709CrossRef

13.

Shimizu H, Imamura H, Ohta K et al (2010) Usefulness of staging laparoscopy for advanced gastric cancer. Surg Today 40:119–124CrossRef

14.

Pasqual EM, Bertozzi S, Bacchetti S et al (2014) Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery. Anticancer Res 34:2363–2368PubMed

Title: Peritoneal dissemination of breast cancer diagnosed by laparoscopy
Authors: Tsuyoshi Nakagawa
Goshi Oda
Akifumi Kikuchi
Toshifumi Saito
Tomoyuki Fujioka
Kazunori Kubota
Mio Mori
Iichiro Onishi
Hiroyuki Uetake
Publication date: 01-01-2021
Publisher: Springer Singapore
Keywords: Laparoscopy
Breast Cancer
Breast Cancer
Peritoneal Cancer
Peritoneal Carcinomatosis
Metastasis
Biomarkers
Published in: International Cancer Conference Journal / Issue 1/2021
Electronic ISSN: 2192-3183
DOI: https://doi.org/10.1007/s13691-020-00456-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Whole brain radiation therapy for primary central nervous system marginal zone lymphoma: a case report

Quadruple gastrointestinal cancer with discordance of mismatch repair protein deficiency and microsatellite instability suggesting Lynch syndrome

Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case

Bulky peritoneal carcinosarcoma with tiny high-grade serous carcinoma of the fallopian tube: a case report

Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report

A rare case of synchronous bilateral epididymal and testicular metastases of urothelial carcinoma of the bladder after intravesical bacillus Calmette–Guérin

Keynote webinar | Spotlight on antibody–drug conjugates in cancer